2-BROMO-1-(2,6-DIMETHYL-1H-INDOL-3-YL)-PROPAN-1-ONE
|
- $315 - $862
- Product name: 2-BROMO-1-(2,6-DIMETHYL-1H-INDOL-3-YL)-PROPAN-1-ONE
- CAS: 843620-91-7
- MF: C13H14BrNO
- MW: 280.16
- EINECS:
- MDL Number:MFCD03848194
- Synonyms:2-BROMO-1-(2,6-DIMETHYL-1H-INDOL-3-YL)-PROPAN-1-ONE;1-Propanone, 2-bromo-1-(2,6-dimethyl-1H-indol-3-yl)-
4 prices
Selected condition：
Brand
- aablocks
- Matrix Scientific
Package
- 500.00mg
- 500mg
- 1g
- Manufactureraablocks
- Product numberAA00JCY4
- Product description2-Bromo-1-(2,6-dimethyl-1h-indol-3-yl)propan-1-one
- Packaging1g
- Price$862
- Updated2026-05-29
- Buy
- Manufactureraablocks
- Product numberAA00JCY4
- Product description2-Bromo-1-(2,6-dimethyl-1h-indol-3-yl)propan-1-one
- Packaging500mg
- Price$755
- Updated2026-05-29
- Buy
- ManufacturerMatrix Scientific
- Product number064194
- Product description2-Bromo-1-(2,6-dimethyl-1H-indol-3-yl)propan-1-one
- Packaging500mg
- Price$315
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number064194
- Product description2-Bromo-1-(2,6-dimethyl-1H-indol-3-yl)propan-1-one
- Packaging500.00mg
- Price$315
- Updated2026-05-18
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00JCY4 | 2-Bromo-1-(2,6-dimethyl-1h-indol-3-yl)propan-1-one | 1g | $862 | 2026-05-29 | Buy |
| aablocks | AA00JCY4 | 2-Bromo-1-(2,6-dimethyl-1h-indol-3-yl)propan-1-one | 500mg | $755 | 2026-05-29 | Buy |
| Matrix Scientific | 064194 | 2-Bromo-1-(2,6-dimethyl-1H-indol-3-yl)propan-1-one | 500mg | $315 | 2021-12-16 | Buy |
| Matrix Scientific | 064194 | 2-Bromo-1-(2,6-dimethyl-1H-indol-3-yl)propan-1-one | 500.00mg | $315 | 2026-05-18 | Buy |
Properties
Boiling point :394.9±37.0 °C(Predicted)
Density :1.429±0.06 g/cm3(Predicted)
pka :16.04±0.30(Predicted)
Density :1.429±0.06 g/cm3(Predicted)
pka :16.04±0.30(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|